BioSpace News Archive

Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, its chief executive officer, and Robert Ross, M.D., its chief medical officer, will participate in the upcoming H.C. Wainwright Global Healthcare Conference

Satellite Healthcare, the leading nonprofit dialysis provider, announced the retirement of its CEO Rick Barnett effective on January 31, 2021.

Timber Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, announced that it will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference being held virtually from September 14-16, 2020.

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Monday, September 14th at 8:30 a.m. Eastern Time.

Amgen (NASDAQ:AMGN) will present at Morgan Stanley’s 18th Annual Virtual Global Healthcare Conference at 11:45 a.m. ET on Wednesday, Sept. 16, 2020.

Formerly of Wellstar and Sutter Health, Owen Plietz brings decades of health system experience to Kaiser Permanente

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics

Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference taking place September 14 – 16, 2020.

Centene Corporation announced that it plans to expand its offering in the 2021 Health Insurance Marketplace.

CareDx, Inc. announced that it will share the latest clinical data on its AlloSure and AlloSeq cfDNA surveillance tools at the 28th International Congress of The Transplantation Society scheduled to be held virtually from September 13th to September 16th, 2020.